|
Markt geschlossen -
OTC Markets
21:51:28 04.06.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 0.0278 USD | -7.64% |
|
+2.96% | +6.92% |
| 19.05. | Adaptimmune Therapeutics plc meldet Ergebnisse für das am 31. Dezember 2025 abgeschlossene Geschäftsjahr | CI |
| 17.11. | Adaptimmune Therapeutics plc kündigt Wechsel in der Geschäftsführung an | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -7.64% | +2.96% | -13.12% | +355.74% | +6.92% | -52.80% | -96.52% | -99.46% | -99.61% | 7.42 Mio. | |
| -1.67% | -4.78% | +14.20% | +29.18% | +2.89% | +36.76% | -4.34% | +19.73% | +98.86% | 79.3 Mrd. | |
| -0.90% | +2.39% | +34.55% | +78.37% | -0.19% | -19.06% | -35.50% | -44.60% | +58.57% | 59.21 Mrd. | |
| -3.35% | -4.92% | +153.24% | +192.41% | +367.92% | +472.81% | +18.97% | -63.90% | - | 55.09 Mrd. | |
| -6.78% | -4.19% | +0.47% | +9.02% | -12.33% | -3.45% | +28.35% | +2.06% | - | 49.86 Mrd. | |
| -2.43% | -2.35% | -13.71% | -13.98% | -9.26% | +8.33% | +160.40% | +122.19% | +194.56% | 47.9 Mrd. | |
| -1.35% | +0.79% | +4.43% | +11.48% | +24.15% | +65.25% | -18.47% | -36.33% | -28.63% | 32.28 Mrd. | |
| -2.64% | -2.69% | -2.15% | +28.56% | +25.92% | +46.99% | +92.55% | +64.34% | +52.92% | 25.21 Mrd. | |
| -0.09% | +4.98% | +19.84% | +28.97% | +40.98% | +11.00% | +199.86% | +76.66% | - | 23.87 Mrd. | |
| -0.34% | +1.35% | -1.48% | +5.43% | +40.08% | +62.33% | +122.21% | +143.45% | +366.20% | 16.89 Mrd. | |
| +2.73% | 0.00% | +47.26% | +12.74% | -7.45% | -5.13% | +831.69% | +514.02% | +7’580.00% | 16.17 Mrd. | |
| -2.64% | -6.01% | -8.31% | +15.61% | +0.14% | +47.99% | +150.98% | +51.74% | - | 14.97 Mrd. | |
| -0.96% | -3.05% | +5.37% | +12.87% | +8.81% | +10.97% | -31.56% | -22.57% | -32.46% | 12.52 Mrd. | |
| -3.51% | -4.21% | -12.49% | -15.12% | +8.97% | +64.10% | +153.88% | +729.25% | +2’607.76% | 10.42 Mrd. | |
| -1.68% | +1.41% | -3.25% | +13.73% | +42.56% | +137.96% | +179.65% | +505.97% | - | 10.4 Mrd. | |
| -7.66% | -2.89% | +65.41% | +111.43% | +345.71% | +424.21% | +565.94% | +26.70% | - | 8.87 Mrd. | |
| -1.04% | +0.38% | -3.91% | +7.22% | -7.01% | -17.56% | -21.96% | -51.58% | -47.85% | 6.91 Mrd. | |
| -1.40% | +2.85% | +3.33% | +34.62% | +3.39% | -3.50% | +63.86% | -11.18% | - | 6.23 Mrd. | |
| -2.16% | -1.20% | -3.51% | +61.39% | +89.28% | +133.14% | +346.43% | +510.48% | - | 6.09 Mrd. | |
| -3.10% | -0.72% | +3.12% | -12.38% | -32.42% | -48.21% | -40.52% | -74.04% | - | 5.71 Mrd. | |
| Durchschnitt | -2.43% | -0.54% | +14.47% | +48.36% | +46.95% | +68.61% | +133.30% | +118.15% | +977.30% | 24.4 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -2.29% | -1.83% | +25.89% | +43.77% | +54.19% | +81.36% | +86.48% | +61.95% | +574.32% |
- Börse
- Aktien
- A14SUX Aktie
- Sektor Adaptimmune Therapeutics plc
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
